Covered recipient · General Payments record
KAYLA POPE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2021–2024
$563.31
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.22 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $111.40 | 1 |
| Neurocrine BioSciences, Inc. | $87.05 | 3 |
| Alkermes, Inc. | $41.95 | 2 |
| E.R. Squibb & Sons, L.L.C. | $23.03 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $24.60 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120574953 | CMS |
| Alkermes, Inc. | $17.35 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120574955 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.03 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101580284 | CMS |
| Neurocrine Biosciences, Inc. | $36.42 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150817672 | CMS |
| Neurocrine Biosciences, Inc. | $22.43 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150849540 | CMS |
| Neurocrine Biosciences, Inc. | $28.20 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150830182 | CMS |
| Otsuka America Pharmaceutical, Inc. | $111.40 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118907439 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.79 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151542759 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.